Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Early dose reduction of dasatinib does not compromise cli... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials.
0
Authors
Dong‐Yeop Shin
18 more
Dong‐Yeop Shin
•
Sa-Hee Park
16 more
•
Dong‐Wook Kim
Published
June 17, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Leukemia Research
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Gastroenterology
Show all topics
DOI
10.1016/j.leukres.2024.107542
